425: Axalta Reports Record 2025 Earnings, Advances AkzoNobel Merger
Earnings Report and Merger Update
Axalta Coating Systems Ltd. announced record full-year 2025 earnings and strong cash flow, while progressing its proposed merger of equals with AkzoNobel N.V. expected to close in late 2026 or early 2027.
Summary
- Axalta delivered record earnings in 2025, demonstrating business resilience and successful execution of its 2026 A Plan amid a challenging macro environment.
- Full year 2025 Adjusted EBITDA reached a record $1,128 million, with an Adjusted EBITDA margin of 22.0%, 100 basis points above the A Plan target.
- Full year 2025 net sales were $5,117 million, a 3% decrease year-over-year, primarily due to volume declines in North America.
- Fourth quarter 2025 net sales decreased 4% year-over-year to $1,262 million, mainly reflecting lower volumes from a challenging economic environment.
- Record full year Adjusted Diluted EPS of $2.49, a 6% improvement over 2024.
- Record full year cash provided by operating activities of $649 million, an increase of $73 million year-over-year.
- Free cash flow for the full year was $466 million, up from $451 million in 2024.
- The net debt to LTM Adjusted EBITDA ratio was 2.3x, the lowest in company history.
- The proposed all-stock merger of equals with AkzoNobel is progressing, expected to close in late 2026 or early 2027, subject to shareholder and regulatory approvals.
- Axalta provided Q1 2026 guidance: Adjusted EBITDA of $240-$250 million and Adjusted Diluted EPS of approximately $0.50.
- Full year 2026 guidance includes Adjusted EBITDA of $1,140-$1,170 million, Adjusted Diluted EPS of $2.55-$2.70, and Free Cash Flow greater than $500 million.
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a strong performance, with Axalta exceeding key profitability targets and demonstrating financial discipline, while also advancing a transformative merger that promises significant future value.
Positives
- Record full year 2025 Adjusted EBITDA of $1,128 million.
- Adjusted EBITDA margin of 22.0% for FY 2025, 100 basis points above the 2026 A Plan target.
- Record full year Adjusted Diluted EPS of $2.49, a 6% increase year-over-year.
- Record full year cash provided by operating activities of $649 million, up $73 million from 2024.
- Record fourth quarter cash provided by operating activities of $344 million, an increase of $110 million year-over-year.
- Record fourth quarter free cash flow of $290 million, an increase of $113 million year-over-year.
- Lowest net debt to LTM Adjusted EBITDA ratio in company history at 2.3x.
- Successful execution of the 2026 A Plan amid a challenging macro environment.
- Mobility Coatings segment achieved a record fourth quarter Adjusted EBITDA of $92 million, with a 300 basis point margin improvement year-over-year.
- Reduced interest expense by $29 million year-over-year.
- Returned $165 million to shareholders through share repurchases in 2025.
- Gross debt reduction of $230 million in 2025.
- Significant cumulative variable cost savings of over $300 million from 2023-2025.
- Over $150 million improvement in operating expenses, down 6% year-over-year.
- Approximately 40% reduction in safety incidents year-over-year in 2025.
- Merger with AkzoNobel is expected to create a premier global coatings company with highly achievable cost synergies of approximately $600 million and anticipated 100-200 bps of revenue synergies.
Negatives
- Full year 2025 net sales decreased 3% year-over-year to $5,117 million, primarily due to volume declines in North America.
- Fourth quarter 2025 net sales decreased 4% year-over-year to $1,262 million, primarily reflecting lower volumes from a challenging economic environment.
- Fourth quarter net income was $60 million, down from $137 million in the prior year, driven by higher income tax expense, lower net sales, and increased merger and acquisition related costs.
- Full year net income decreased by $12 million over 2024 to $379 million, reflecting lower volumes and higher income tax expense.
- Performance Coatings segment saw a 6% decrease in Q4 net sales and a 9% decrease in Adjusted EBITDA year-over-year, mainly due to lower volumes in North America and Europe.
- Refinish net sales declined 7% year-over-year in Q4 due to reduced claims activity and customer inventory dynamics in North America.
- Industrial net sales decreased 5% year-over-year in Q4 due to lower industry activity.
- Diluted EPS declined by 2% to $1.74 for the full year 2025.
- Capital expenditures increased to $196 million in 2025 from $140 million in 2024, driven by productivity investments.
Risks
- Economic, competitive, governmental (including tariffs and retaliatory actions), and technological factors outside of Axalta's control.
- Risks related to the proposed merger with AkzoNobel, including the ability to consummate the transaction and realize anticipated benefits (e.g., value creation, cost synergies, EPS accretion, improved liquidity, revenue synergies, adjusted EBITDA margins, cash flow generation, NYSE listing, credit rating improvement).
- Execution of, and assumptions underlying, tariff mitigation strategies, the 2024 Transformation Initiative, and the 2026 A Plan.
- Uncertainty in forward-looking statements based on management's expectations, estimates, and assumptions.
- Final results for the full year 2025, to be reported in the 2025 Form 10-K, may vary from preliminary estimates due to completion of financial closing procedures and recognition of subsequent events.
- A condition to the closing of the proposed transaction may not be satisfied.
- The occurrence of any event that can give rise to termination of the proposed transaction.
- Regulatory approval for the proposed transaction may be delayed, not obtained, or obtained subject to unanticipated conditions.
- Inability to achieve the synergies and value creation contemplated by the proposed transaction.
- Inability to promptly and effectively integrate businesses post-merger.
- Management's time and attention diverted on transaction-related issues.
- Possibility of competing offers or acquisition proposals.
- Disruption from the proposed transaction making it more difficult to maintain business, contractual, and operational relationships.
- Credit ratings of AkzoNobel or Axalta declining following the proposed transaction.
- Legal proceedings instituted against AkzoNobel or Axalta, including resulting expense or delay.
- Inability to retain or hire key personnel.
- Negative effect of the communication or consummation of the proposed acquisition on the market price of capital stock or operating results.
- Evolving legal, regulatory, and tax regimes.
- Changes in economic, financial, political, and regulatory conditions in the Netherlands, the United States, and elsewhere.
- Natural and man-made disasters, civil unrest, pandemics, geopolitical uncertainty, and conditions from legislative, regulatory, trade, and policy changes.
- Ability to successfully recover from business continuity problems (e.g., hurricane, flood, earthquake, terrorist attack, war, pandemic, security breach, cyber-attack, power loss, telecommunications failure).
- Impact of public health crises and related governmental policies.
- Actions by third parties, including government agencies.
- Certain restrictions during the pendency of the acquisition that may impact business opportunities or strategic transactions.
- Ability to meet expectations regarding accounting and tax treatments of the proposed transaction.
Future Outlook
Axalta anticipates continued strong financial performance, guiding for full year 2026 Adjusted EBITDA between $1,140 million and $1,170 million, Adjusted Diluted EPS of $2.55 to $2.70, and Free Cash Flow exceeding $500 million. The proposed merger with AkzoNobel is expected to close in late 2026 or early 2027, aiming to create a premier global coatings company with significant synergy opportunities and long-term value creation.
Management Comments
- "We delivered record earnings in 2025, demonstrating the resilience of our business and the successful execution of our 2026 A Plan in the midst of a challenging macro environment."
- "We are building top line momentum, and our 2025 Adjusted EBITDA margin was 22%—one of the highest in the company’s history and 100 basis points above our A Plan target."
- "Looking ahead, we will continue to leverage the strong foundation we’ve established to drive further improvement in our financial performance."
- "Axalta’s balance sheet is strong, and we believe our proven portfolio and ability to navigate any operating environment will enable us to deliver meaningful value to shareholders as we prepare for our next chapter with AkzoNobel."
- "We are also continuing to work toward closing our merger with AkzoNobel in late 2026 to early 2027, subject to approval by shareholders of both Axalta and AkzoNobel."
Industry Context
StockSavvy.ai notes that Axalta's performance, particularly its record Adjusted EBITDA and strong cash flow generation in a challenging macro environment, positions it favorably within the global coatings industry. The ongoing consolidation trend, exemplified by the proposed merger with AkzoNobel, reflects a strategic move by industry players to achieve greater scale, operational efficiencies, and market leadership. The focus on cost management and operational excellence, as highlighted by Axalta's 2026 A Plan, is a common theme among leading chemical and materials companies seeking to mitigate volume pressures and maintain profitability.
Comparison to Industry Standards
- Axalta's 2025 Adjusted EBITDA margin of 22.0% is noted as "one of the highest in the company's history" and 100 basis points above its 2026 A Plan target, indicating strong operational efficiency relative to internal benchmarks.
- The proposed merger with AkzoNobel, a major global coatings company, aims to create a combined entity with $17 billion in net sales (2024 figures), positioning it as a premier global player. This scale would be comparable to industry giants like PPG Industries and Sherwin-Williams, which also operate globally across diverse coatings segments.
- The anticipated cost synergies of approximately $600 million and revenue synergies of 100-200 basis points from the AkzoNobel merger are substantial, suggesting a strong strategic rationale for the transaction, similar to the synergy targets seen in other large-scale chemical industry mergers.
- Axalta's net debt to LTM Adjusted EBITDA ratio of 2.3x is the "lowest in company history," indicating a robust balance sheet and strong financial discipline, which compares favorably to many industrial peers who might carry higher leverage ratios, especially during periods of M&A activity.
Stakeholder Impact
- Shareholders: Expected to benefit from the proposed merger with AkzoNobel through significant EPS accretion, value creation, enhanced liquidity, and potential credit rating improvement for the combined company. Also benefited from $165 million in share repurchases in 2025.
- Employees: The merger will combine two complementary portfolios, potentially leading to integration activities and changes, though specific impacts are not detailed.
- Customers: The combined company is expected to offer a top-tier portfolio with leading positions across seven key end-markets and ~100 globally recognized brands, supported by cutting-edge R&D and innovation.
- Creditors: Gross debt reduction of $230 million in 2025 and the lowest net debt to LTM Adjusted EBITDA ratio in company history (2.3x) indicate improved creditworthiness. The merger could also impact credit ratings.
Next Steps
- Continue working toward closing the merger with AkzoNobel in late 2026 to early 2027.
- File the proxy statement for the merger.
- File the Annual Report on Form 10-K for the year ended December 31, 2025, with the SEC on or around February 13, 2026.
- AkzoNobel will file a registration statement on Form F-4, including Axalta's proxy statement/prospectus, with the SEC.
- Shareholders of both Axalta and AkzoNobel need to approve the merger.
- Regulatory approvals are required for the merger.
Key Dates
| Date | Description |
|---|---|
| 2020-01-01 | Intra-entity transfer of certain intellectual property rights (related to deferred tax benefit amortization). |
| 2024-02-13 | Axalta's Annual Report on Form 10-K for fiscal year ended December 31, 2024, filed with the SEC. |
| 2025-01-21 | Current Report on Form 8-K furnished to the SEC regarding non-GAAP reporting changes. |
| 2025-02-19 | Statements of Beneficial Ownership on Form 3, 4, or 5 filed with the SEC. |
| 2025-03-04 | Statements of Beneficial Ownership on Form 3, 4, or 5 filed with the SEC. |
| 2025-03-06 | Statements of Beneficial Ownership on Form 3, 4, or 5 filed with the SEC. |
| 2025-04-22 | Axalta's proxy statement for its 2025 annual meeting of stockholders filed with the SEC. |
| 2025-08-05 | Statements of Beneficial Ownership on Form 3, 4, or 5 filed with the SEC. |
| 2025-08-18 | Statements of Beneficial Ownership on Form 3, 4, or 5 filed with the SEC. |
| 2025-08-21 | Statements of Beneficial Ownership on Form 3, 4, or 5 filed with the SEC. |
| 2025-09-23 | Statements of Beneficial Ownership on Form 3, 4, or 5 filed with the SEC. |
| 2025-11-01 | Approximate date Axalta announced definitive agreement to combine with AkzoNobel in an all-stock merger of equals. |
| 2025-12-31 | End of fiscal year 2025. |
| 2026-02-10 | Axalta released Fourth Quarter and Full Year 2025 financial results. |
| 2026-02-10 | Conference call to discuss Q4 and FY 2025 financial results at 8:00 a.m. ET. |
| 2026-02-11 | Filing date of this 425 communication. |
| 2026-02-13 | Approximate date Axalta's Annual Report on Form 10-K for the year ended December 31, 2025, to be filed with the SEC. |
| 2026-02-17 | Replay of conference call available until this date. |
| 2026-12-31 | Expected closing of merger with AkzoNobel (late 2026 to early 2027). |
| 2027-01-01 | Expected closing of merger with AkzoNobel (late 2026 to early 2027). |
Recommendation
buyAxalta's strong financial performance in 2025, marked by record Adjusted EBITDA and cash flow, coupled with exceeding its A Plan profitability targets, demonstrates robust operational execution in a challenging market. The company's deleveraging efforts, achieving the lowest net debt ratio in its history, further strengthen its financial position. The proposed merger with AkzoNobel is a transformative strategic move, promising substantial synergies and long-term value creation, which, if successfully executed, should significantly enhance the combined entity's market position and profitability. The positive 2026 guidance reinforces confidence in continued performance. These factors collectively suggest a compelling investment opportunity.
Keywords
Coatings, Axalta, AkzoNobel, Merger, Earnings, Financial Results, Adjusted EBITDA, Free Cash Flow, Q4 2025, FY 2025, 2026 Guidance, Performance Coatings, Mobility Coatings, Refinish, Industrial, M&A, Shareholder Value
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.